Evaluation of different pretreatment protocols to detect accurately clinical carbapenemase-producing Enterobacteriaceae by MALDI-TOF

Journal of Antimicrobial Chemotherapy

Volumn 71, Issue 10, 2016, Pages 2856-2867

  Monteferrante, Carmine G ^a   Sultan, Sadaf ^a   ten Kate, Marian T ^a   Dekker, Lennard J M ^a   Sparbier, Katrin ^b   Peer, Markus ^b   Kostzrewa, Markus ^b   Luider, Theo M ^a   Goessens, Wil H F ^a   Burgers, Peter C ^a,c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b BRUKER DALTONIK GMBH   (Germany)

^c TI COAST ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; CARBAPENEM; CARBAPENEMASE; ERTAPENEM; IMIPENEM; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAM; BETA LACTAMASE; CARBAPENEM DERIVATIVE;

ARTICLE; BACTERIAL CELL; BACTERIAL STRAIN; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME STRUCTURE; EVALUATION STUDY; HYDROLYSIS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PREMEDICATION; ACINETOBACTER; BACTERIUM; BIOSYNTHESIS; CHEMISTRY; DRUG EFFECTS; ENTEROBACTER AEROGENES; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ENZYMOLOGY; HUMAN; ISOLATION AND PURIFICATION; KLEBSIELLA PNEUMONIAE; LABORATORY TECHNIQUE; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PHYSIOLOGY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ACINETOBACTER; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL PROTEINS; BETA-LACTAMASES; BETA-LACTAMS; CARBAPENEMS; CLINICAL LABORATORY TECHNIQUES; ENTEROBACTER AEROGENES; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; HYDROLYSIS; IMIPENEM; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84994691698     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkw208     Document Type: Article

References (44)

1. Lewis K. Platforms for antibiotic discovery. Nat Rev Drug Discov 2013; 12: 371-87.
2. Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 2013; 9: 228-36.
3. Texier-Maugein J, Allaouchiche B, Saux MC et al. Carbapenems. J Chemother 2013; 25: 1-17.
4. Papp-Wallace KM, Endimiani A, Taracila MA et al. Carbapenems: past, present, and future. Antimicrob Agents Chemother 2011; 55: 4943-60.
5. Nordmann P, Dortet L, Poirel L. Carbapenem resistance in Enterobacteriaceae: here is the storm! Trends Mol Med 2012; 18: 263-72.
6. Gazin M, Paasch F, Goossens H et al. Current trends in culture-based and molecular detection of extended-spectrum-b-lactamase-harboring and carbapenem-resistant Enterobacteriaceae. J ClinMicrobiol 2012; 50: 1140-6.
7. Hrabák J, Chudácková E, Papagiannitsis CC. Detection of carbapenemases in Enterobacteriaceae: a challenge for diagnostic microbiological laboratories. Clin Microbiol Infect 2014; 20: 839-53.
8. Nordmann P, Poirel L, Dortet L. Rapid detection of carbapenemaseproducing Enterobacteriaceae. Emerg Infect Dis 2012; 18: 1503-7.
9. Dortet L, Bréchard L, Cuzon G et al. Strategy for rapid detection of carbapenemase-producing Enterobacteriaceae. Antimicrob Agents Chemother 2014; 58: 2441-5.
10. Buchan BW, Ledeboer NA. Emerging technologies for the clinical microbiology laboratory. Clin Microbiol Rev 2014; 27: 783-822.
11. Clark AE, Kaleta EJ, Arora A et al. Matrix-assisted laser desorption ionization-time of flight mass spectrometry: a fundamental shift in the routine practice of clinical microbiology. Clin Microbiol Rev 2013; 26: 547-603.
12. Seng P, Rolain JM, Fournier PE et al. MALDI-TOF-mass spectrometry applications in clinical microbiology. Future Microbiol 2010; 5: 1733-54.
13. Wieser A, Schneider L, Jung J et al. MALDI-TOF MS in microbiological diagnostics-identification of microorganisms and beyond. Appl Microbiol Biotechnol 2012; 93: 965-74.
14. Hrabá k J, Walkova R, Studentova V et al. Carbapenemase activity detection by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 2011; 49: 3222-7.
15. Sparbier K, Schubert S, Weller U et al. Matrix-assisted laser desorption ionization-time of flight mass spectrometry-based functional assay for rapid detection of resistance against b-lactam antibiotics. J Clin Microbiol 2012; 50: 927-37.
16. KostrzewaM, Sparbier K, Maier Tet al. MALDI-TOF MS: an upcoming tool for rapid detection of antibiotic resistance in microorganisms. Proteomics Clin Appl 2013; 7: 767-78.
17. Sparbier K, Weller U, Boogen C et al. Rapid detection of Salmonella sp. by means of a combination of selective enrichment broth and MALDI-TOF MS. Eur J Clin Microbiol Infect Dis 2012; 31: 767-73.
18. Hrabák J, Chudácková E, Walková R. Matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry for detection of antibiotic resistance mechanisms: from research to routine diagnosis. Clin Microbiol Rev 2013; 26: 103-14.
19. Kulkarni MV, Zurita AN, Pyka JS et al. Use of imipenem to detect KPC, NDM, OXA, IMP, and VIM carbapenemase activity from gram-negative rods in 75 minutes using liquid chromatography-tandem mass spectrometry. J Clin Microbiol 2014; 52: 2500-5.
20. Jung JS, Popp C, Sparbier K et al. Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for rapid detection of b-lactam resistance in Enterobacteriaceae derived from blood cultures. J Clin Microbiol 2014; 52: 924-30.
21. Vogne C, Prod'HomG, Jaton K et al. A simple, robust and rapid approach to detect carbapenemases in Gram negative isolates by MALDI-TOF mass spectrometry: validation with triple quadripole tandem mass spectrometry, microarray and PCR. Clin Microbiol Infect 2014; 20: O1106-12.
22. Lasserre C, De Saint Martin L, Cuzon G et al. Efficient detection of carbapenemase activity in Enterobacteriaceae by matrix-assisted laser desorption ionization-time of flight mass spectrometry in less than 30 minutes. J Clin Microbiol 2015; 53: 2163-71.
23. Hooff GP, Van Kampen JJA, Meesters RJW et al. Characterization of b-lactamase enzyme activity in bacterial lysates using MALDI-mass spectrometry. J Proteome Res 2012; 11: 79-84.
24. Burckhardt I, Zimmermann S. Using matrix-assisted laser desorption ionization-time of flight mass spectrometry to detect carbapenem resistance within 1 to 2.5 hours. J Clin Microbiol 2011; 49: 3321-4.
25. Bhaduri S, Demchick PH. Simple and rapid method for disruption of bacteria for protein studies. Appl Environ Microbiol 1983; 46: 941-3.
26. Uri JV. Detection of b-lactamase activity with nitrocefin of multiple strains of various microbial genera. Acta Microbiol Hung 1985; 32: 133-45.
27. Masuda G, Tomioka S, Hasegawa M. Detection of b-lactamase production by gram-negative bacteria. J Antibiot (Tokyo) 1976; 29: 662-4.
28. Suckau D, Resemann A, SchuerenbergMet al. A novelMALDI LIFT-TOF/TOF mass spectrometer for proteomics. Anal Bioanal Chem 2003; 376: 952-65.
29. van Kampen JJ, Burgers PC, de Groot R et al. Qualitative and quantitative analysis of pharmaceutical compounds by MALDI-TOF mass spectrometry. Anal Chem 2006; 78: 5403-11.
30. Knochenmuss R, Karbach V, Wiesli U et al. The matrix suppression effect in matrix-assisted laser desorption/ionization: application to negative ions and further characteristics. Rapid Commun Mass Spectrom 1998; 12: 529-34.
31. Kim Y, Cunningham MA, Mire J et al. NDM-1, the ultimate promiscuous enzyme: substrate recognition and catalytic mechanism. FASEB J 2013; 27: 1917-27.
32. Poirel L, Potron A, Nordmann P. OXA-48-like carbapenemases: the phantom menace. J Antimicrob Chemother 2012; 67: 1597-606.
33. Studentova V, Papagiannitsis CC, Izdebski R et al. Detection of OXA-48-type carbapenemase-producing Enterobacteriaceae in diagnostic laboratories can be enhanced by addition of bicarbonates to cultivation media or reaction buffers. Folia Microbiol (Praha) 2015; 60: 119-29.
34. Nordmann P, Poirel L, Walsh TR et al. The emerging NDM carbapenemases. Trends Microbiol 2011; 19: 588-95.
35. Docquier JD, Calderone V, De Luca F et al. Crystal structure of the OXA-48 b-lactamase reveals mechanistic diversity among class D carbapenemases. Chem Biol 2009; 16: 540-7.
36. Smith GB, Dezeny GC, Douglas AW. Stability and kinetics of degradation of imipenemin aqueous solution. J Pharm Sci 1990; 79: 732-40.
37. Patel R. MALDI-TOF MS for the diagnosis of infectious diseases. Clin Chem 2015; 61: 100-11.
38. Pradel N, Delmas J, Wu LF et al. Sec-and Tat-dependent translocation of b-lactamases across the Escherichia coli inner membrane. Antimicrob Agents Chemother 2009; 53: 242-8.
39. Cohen Stuart J, Leverstein-Van Hall MA; Dutch Working Party on the Detection of Highly Resistant Microorganisms. Guideline for phenotypic screening and confirmation of carbapenemases in Enterobacteriaceae. Int J Antimicrob Agents 2010; 36: 205-10.
40. Walsh TR, Toleman MA, Poirel L et al. Metallo-b-lactamases: the quiet before the storm? Clin Microbiol Rev 2005; 18: 306-25.
41. Pasteran F, Mendez T, Rapoport M et al. Controlling false-positive results obtained with the Hodge and Masuda assays for detection of class A carbapenemase in species of Enterobacteriaceae by incorporating boronic acid. J Clin Microbiol 2010; 48: 1323-32.
42. Drawz SM, Papp-Wallace KM, Bonomo RA. New b-lactamase inhibitors: a therapeutic renaissance in an MDR world. Antimicrob Agents Chemother 2014; 58: 1835-46.
43. Drawz SM, Bonomo RA. Three decades of b-lactamase inhibitors. Clin Microbiol Rev 2010; 23: 160-201.
44. Mirande C, Canard I, Buffet Croix Blanche S et al. Rapid detection of carbapenemase activity: benefits andweaknesses of MALDI-TOF MS. Eur J Clin Microbiol Infect Dis 2015; 34: 2225-34.